Astone, Antonio
 Distribuzione geografica
Continente #
EU - Europa 436
NA - Nord America 435
AS - Asia 119
AF - Africa 6
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.000
Nazione #
US - Stati Uniti d'America 435
DE - Germania 155
SE - Svezia 102
CN - Cina 55
IT - Italia 39
UA - Ucraina 39
IE - Irlanda 27
SG - Singapore 22
GB - Regno Unito 18
FR - Francia 16
ID - Indonesia 15
IN - India 13
RU - Federazione Russa 11
FI - Finlandia 7
CI - Costa d'Avorio 6
IR - Iran 5
RS - Serbia 5
BE - Belgio 4
NL - Olanda 4
TR - Turchia 4
ES - Italia 3
CH - Svizzera 2
HK - Hong Kong 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 1.000
Città #
Chandler 108
Dublin 26
Ashburn 21
Singapore 19
Jacksonville 18
San Mateo 18
Jakarta 14
Boston 13
Nanjing 13
New York 13
Ann Arbor 12
Princeton 11
Chicago 9
Dearborn 9
Wilmington 9
Hangzhou 8
Simi Valley 8
Houston 7
Milan 7
Moscow 7
Abidjan 6
Falls Church 6
Los Angeles 6
Marseille 6
Woodbridge 6
Belgrade 5
Bologna 5
Nanchang 5
Nürnberg 5
Rome 5
Augusta 4
Fairfield 4
Fremont 4
Izmir 4
Leawood 4
Mountain View 4
Norwalk 4
Brussels 3
Cattolica 3
Changchun 3
Kunming 3
Redwood City 3
San Diego 3
Shenyang 3
Boardman 2
Bremen 2
Busto Arsizio 2
Hefei 2
Hong Kong 2
Hyderabad 2
Jiaxing 2
Jinan 2
Lawrence 2
Legnano 2
Madrid 2
Palermo 2
San Francisco 2
Stockholm 2
Tokyo 2
University Park 2
Zhengzhou 2
Zurich 2
Antwerp 1
Beijing 1
Cambridge 1
Charleston 1
Clearwater 1
Cormeilles-en-Parisis 1
Costa Mesa 1
Edinburgh 1
Fiesole 1
Forest City 1
Fort Worth 1
Fuzhou 1
Guangzhou 1
Haikou 1
Hebei 1
Hounslow 1
Kish 1
Lancaster 1
Lima 1
Lisbon 1
Miami 1
Monmouth Junction 1
Munich 1
Ningbo 1
Pantigliate 1
Paris 1
Phoenix 1
Pune 1
Redmond 1
Riyadh 1
Santa Clara 1
Santiago 1
Seattle 1
Shaoxing 1
Sofia 1
Sydney 1
Tehran 1
Tettnang 1
Totale 528
Nome #
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 145
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 123
AMAROS Study: Overall Survival in Breast Cancer Subtypes 106
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 97
The immune response to tumors as a tool toward immunotherapy 86
Advanced colon cancer: staging and prognosis by CEA test 80
Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer 73
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 66
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 54
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 52
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 46
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 43
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 33
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program 17
Totale 1.021
Categoria #
all - tutte 4.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 2 7 5 8 17 4 7 8 17 8
2020/2021100 2 8 2 9 8 5 16 2 17 8 22 1
2021/2022134 8 6 1 16 9 6 4 19 5 8 21 31
2022/2023309 29 51 16 44 19 31 15 23 44 7 19 11
2023/2024114 7 41 2 1 10 11 5 2 6 7 9 13
2024/202531 10 4 17 0 0 0 0 0 0 0 0 0
Totale 1.021